Lichtenberg Dov, Pinchuk Ilya, Yonassi Eleni, Weber Daniela, Grune Tilman
Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Department of Digital Medical Technologies, Holon Institute of Technology, Holon 5810201, Israel.
Antioxidants (Basel). 2023 May 30;12(6):1188. doi: 10.3390/antiox12061188.
The steady-state redox status is physiologically important and therefore homeostatically maintained. Changes in the status result in signaling (eustress) or oxidative damage (distress). Oxidative stress (OS) is a hard-to-quantitate term that can be estimated only based on different biomarkers. Clinical application of OS, particularly for selective antioxidant treatment of people under oxidative stress, requires quantitative evaluation and is limited by the lack of universal biomarkers to describe it. Furthermore, different antioxidants have different effects on the redox state. Hence, as long as we do not have the possibility to determine and quantify OS, therapeutic interventions by the "identify-and-treat" approach cannot be assessed and are, therefore, not likely to be the basis for selective preventive measures against oxidative damage.
稳态氧化还原状态在生理上很重要,因此通过体内平衡维持。这种状态的变化会导致信号传导(良性应激)或氧化损伤(恶性应激)。氧化应激(OS)是一个难以量化的术语,只能基于不同的生物标志物进行估计。OS的临床应用,特别是对处于氧化应激状态的人群进行选择性抗氧化治疗,需要进行定量评估,并且由于缺乏描述它的通用生物标志物而受到限制。此外,不同的抗氧化剂对氧化还原状态有不同的影响。因此,只要我们没有可能确定和量化OS,就无法评估通过“识别并治疗”方法进行的治疗干预,因此,这些干预不太可能成为针对氧化损伤的选择性预防措施的基础。